dr. dickler on monarch 1 results in hr /her2- breast cancer
Published 8 years ago • 503 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
6:07
hr breast cancer: updated results from monarch trials
-
5:06
monarch 1: abemaciclib monotherapy for hr mbc
-
8:39
final overall survival analysis of monarch 1
-
0:50
next steps beyond the monarch 1 trial in breast cancer
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer
-
1:33
ongoing trial of abemaciclib and pembrolizumab in hr /her2-negative breast cancer
-
4:45
monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer
-
3:06
hr breast cancer: pooled analysis from monarch 2 and 3
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
2:58
dr. goetz discusses a secondary analysis of the monarch trials in breast cancer
-
0:52
dr. graff on genomic risk prediction in hr /her2- breast cancer
-
1:39
dr. ellis on abemaciclib in hr-positive breast cancer
-
0:45
nancy lin, md, explores the role of cdk4/6 inhibitors in metastatic breast cancer management
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
0:59
dr. accordino on data from the pearl trial in hr /her2- metastatic breast cancer
-
9:18
monarch 3: abemaciclib with endocrine therapy for mbc
-
18:07
emerging evidence on the role of cdk4/6 inhibitors in early bc